Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
10 /100
LOW RISK
Score updated Jul 28, 2026

HQY — HealthEquity, Inc. Dilution Risk Tracker

Track HQY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HQY — Get alerts when the score changes →

As of July 28, 2026, HealthEquity, Inc. (HQY) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. HealthEquity, Inc. has a market capitalization of $7.36B, 83.60M shares outstanding, 490 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for HQY.
🔔 Track HQY — Get forecast alerts →

Market Data

Market Cap$7.36B
Shares Outstanding83.60M
Float81.95M
Cash$265.37M
Debt$942.66M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 7.2% shares (2026Q1 vs prior)
490 institutional holders · 97.88M shares
#1 BlackRock, Inc. 10.53M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 7.65M shares
#3 WASATCH ADVISORS LP 7.20M shares
+ 17 more holders Sign up free to view →

Short Interest

Short Interest5.04M
Days to Cover6.0
% of Float6.2%
FINRA data as of Jul 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-07-07
xbrl XBRL CONVERTIBLE 2015-01-31
4 INSIDER TRANSACTION 2026-04-08
4 INSIDER TRANSACTION 2026-04-08
4 INSIDER TRANSACTION 2026-04-08
Full SEC filing analysis available with free account

Recent News

No recent news

What This Means for HQY Shareholders

HealthEquity, Inc. (HQY) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 28, 2026.

DilutionWatch's EDGAR monitoring for HQY shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for HQY in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for HQY alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding HQY's Dilution Risk Factors

Primary Risk Drivers

The highest-scoring factors for dilution risk are Offering Ability, Warrant Exposure, and Convertible Note Risk. While these factors are not currently at extreme levels, they represent potential pathways for future dilution. Offering Ability refers to the company’s capacity to issue new shares, which could increase the total number of shares outstanding and dilute existing shareholders. Warrant Exposure indicates the number of warrants outstanding that may be exercised in the future, which could lead to additional shares being issued. Similarly, Convertible Note Risk relates to debt that may be converted into equity, increasing the share count if conversion occurs.

Factors Currently Not a Concern

The Cash Runway and Float Risk factors are currently low risk. The Cash Runway score of 0 indicates the company has ample cash with no near-term concern, which means the company is not under pressure to raise capital through equity offerings. Float Risk is also low, but this could change if the company issues a large number of new shares or if there is a significant increase in the number of shares available for trading. These changes would likely be reflected in SEC filings or public disclosures.

SEC Filings to Watch

Specific SEC filings to monitor include S-3, which is used for shelf registrations and could signal future equity offerings. A 424B5 filing would indicate the details of a specific offering, while an 8-K Item 1.01 filing would disclose significant events such as the exercise of warrants or the conversion of convertible notes. A 10-Q filing provides quarterly financial updates and may include information about dilutive events or changes in the company’s capital structure.

How Dilution Happens

Dilution occurs when new shares are issued, increasing the total number of shares outstanding. For example, if the company issues new shares through an offering, existing shareholders’ ownership percentages decrease. Similarly, if warrants are exercised or convertible notes are converted into equity, additional shares are added to the float, further diluting existing shareholders. This process reduces the value of each share and can negatively impact returns for current holders.

What Would Make This Worse

A significant deterioration in the risk profile could occur if the company faces unexpected financial pressure, leading to a need for rapid capital raising. This could trigger a large equity offering, increasing the share count substantially. Additionally, if a large number of warrants are exercised or convertible notes are converted simultaneously, the dilution effect could be amplified. These events would likely be accompanied by increased SEC filings and public disclosures, signaling heightened dilution risk.

Key Insight

While HQY currently presents minimal dilution risk, monitoring future SEC filings and capital structure changes is critical for understanding potential dilution pathways.

How to Monitor HQY for Dilution Risk

What This Risk Level Means

A DilutionScore of 10/100 indicates that HealthEquity, Inc. (HQY) currently presents a LOW risk of dilution. For a mid-cap large-cap operating company, this score suggests that the company is not currently engaging in activities that would significantly increase the number of outstanding shares. This is a favorable position, as it implies that the company is not relying heavily on equity financing, and its capital structure is relatively stable at this time.

What Typically Happens Next

Companies at this risk level may not see immediate dilution activity. However, it is common for firms to prepare for future capital needs by registering shares on a shelf or setting up an ATM program. These steps are often taken in advance of potential financing events, such as mergers, acquisitions, or growth initiatives. Warrant exercises may also occur if existing warrants are approaching expiration and are in-the-money.

Monitoring Playbook

Use DilutionWatch to track HQY's dilution risk. Set up alerts for any changes in the DilutionScore, and monitor for new filings related to shelf registrations or ATM programs. Check the score at least monthly, or more frequently if the company is near a known event. If the score rises above 30, investigate the cause and consider using Shelf & ATM Monitor to track any new filings or share issuance activity.

Early Warning Signals

  • A sudden increase in the DilutionScore above 30/100, indicating heightened dilution risk.
  • Filings related to new shelf registrations or ATM programs, which may signal upcoming share issuance.
  • Exercises of warrants or convertible securities that increase the number of outstanding shares.

What a Positive Resolution Looks Like

A positive resolution would involve actions that reduce dilution risk, such as the completion of a capital raise that strengthens the balance sheet, the paydown of debt, or the expiration of warrants without exercise. These actions would lead to a more stable capital structure and a lower DilutionScore over time.

Watch For

Watch for any increase in the DilutionScore or new filings related to share issuance. These could signal a shift in the company's capital strategy and increased dilution risk.

Full SEC filing analysis available with free account  →
Track HQY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HQY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for HQY
HQY FDA Catalyst Timeline & Biotech Grade — BiotechSignsHQY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.